1. Home
  2. SUPN vs HI Comparison

SUPN vs HI Comparison

Compare SUPN & HI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SUPN
  • HI
  • Stock Information
  • Founded
  • SUPN 2005
  • HI 2007
  • Country
  • SUPN United States
  • HI United States
  • Employees
  • SUPN N/A
  • HI N/A
  • Industry
  • SUPN Biotechnology: Pharmaceutical Preparations
  • HI Miscellaneous manufacturing industries
  • Sector
  • SUPN Health Care
  • HI Consumer Discretionary
  • Exchange
  • SUPN Nasdaq
  • HI Nasdaq
  • Market Cap
  • SUPN 2.6B
  • HI 2.2B
  • IPO Year
  • SUPN 2012
  • HI N/A
  • Fundamental
  • Price
  • SUPN $46.02
  • HI $31.68
  • Analyst Decision
  • SUPN Strong Buy
  • HI Hold
  • Analyst Count
  • SUPN 4
  • HI 3
  • Target Price
  • SUPN $63.25
  • HI $32.00
  • AVG Volume (30 Days)
  • SUPN 1.0M
  • HI 3.5M
  • Earning Date
  • SUPN 11-04-2025
  • HI 11-19-2025
  • Dividend Yield
  • SUPN N/A
  • HI 2.84%
  • EPS Growth
  • SUPN N/A
  • HI N/A
  • EPS
  • SUPN N/A
  • HI N/A
  • Revenue
  • SUPN $681,539,000.00
  • HI $2,859,300,000.00
  • Revenue This Year
  • SUPN $8.29
  • HI N/A
  • Revenue Next Year
  • SUPN $22.72
  • HI N/A
  • P/E Ratio
  • SUPN N/A
  • HI N/A
  • Revenue Growth
  • SUPN 4.54
  • HI N/A
  • 52 Week Low
  • SUPN $29.16
  • HI $18.36
  • 52 Week High
  • SUPN $57.65
  • HI $35.59
  • Technical
  • Relative Strength Index (RSI)
  • SUPN 37.29
  • HI 71.97
  • Support Level
  • SUPN $43.11
  • HI $31.41
  • Resistance Level
  • SUPN $57.34
  • HI $31.67
  • Average True Range (ATR)
  • SUPN 2.50
  • HI 0.09
  • MACD
  • SUPN -0.98
  • HI -0.18
  • Stochastic Oscillator
  • SUPN 19.60
  • HI 83.02

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.

About HI Hillenbrand Inc

Hillenbrand Inc is a industrial company that provides engineered processing equipment and solutions to customers around the world. The company operates through two segments. The Advanced Process Solutions segment designs, develops, manufactures, and services engineered industrial equipment and also provider of engineered process and material handling equipment, systems, and aftermarket parts and services for a variety of industries, including durable plastics, food, and recycling. Molding Technology Solutions has a comprehensive product portfolio that includes injection molding and extrusion equipment, It earns it revenue from Advanced Process Solutions, and Geographically from America, following by Asia and EMEA.

Share on Social Networks: